-
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards
Biotech Newswire
March 27, 2024
Vetter once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents.
-
Why Diverse Representation in Clinical Research Matters
Suzanne Elvidge
March 19, 2024
Randomised controlled trials (RCTs), where study participants are randomly allocated to an experimental group or a control group, became the ‘gold standard’ of clinical research in the mid-20th century.
-
Understanding clinical trials in approval of novel medication into the health market
Shruti Talashi
December 01, 2023
The first step in creating a new medication is to gain as much knowledge as you can about the illness or condition. Basic research offers hints about prospective treatment approaches for illnesses, including addressing their symptoms or underlying causes.
-
Breakthroughs in Melanoma Immunotherapy & RNA Vaccines
Daivd Orchard Webb/PharmaSources
July 03, 2023
Melanoma is a type of skin cancer that develops from pigment-producing cells called melanocytes.
-
The Dynamic Diabetes and Metabolic Disorder Treatment Landscape
Daivd Orchard Webb/PharmaSources
July 03, 2023
Diabetes is a chronic medical condition characterized by high levels of glucose in the blood.
-
Weekly Pharma News Review | PharmaSources.com (May.6th to May.15th)
PharmaSources.com
May 18, 2022
The most encouraging news this week is that the international, multicenter, Phase III clinical trials of Hengrui's PD-1 combination therapy for liver cancer have been announced to be successful.
-
Weekly Pharma News Review | PharmaSources.com (April.18th - 22ed)
PharmaSources.com
April 27, 2022
The pharma news review of this week totally covers 22 pieces of news in 3 sections, including drug review, R&D, and business.
-
With the BGB-16673 Clinical Trials of BeiGene Launched, PROTAC Leads a Brand New Trend of Global Competition
PharmaSources/Wanghong
March 21, 2022
On February 28, BGB-16673, a BTK-targeted PROTAC drug of BeiGene, was launched for clinical trials for the first time in China.
-
Innovent's PD-1 suffered setbacks in the listing of overseas market, a paradigm for Chinese innovative drug in the global market
PharmaSources/Caicai
February 22, 2022
Recently, FDA held an ODAC (Oncologic Drugs Advisory Committee) meeting around the key event in the listing application of Sintilimab, Innovent's PD-1 monoclonal antibody, in the United States.
-
Decentralized Clinical Trials— The Tomorrow of Clinical Research
Lin Zhang
April 07, 2021
The Coronavirus disease 2019 (COVID-19) pandemic has led to many changes in the way different processes are handled. In particular, it is profoundly disrupting clinical research.